Liquidia (LQDA) Accumulated Expenses (2019 - 2026)
Liquidia (LQDA) recorded quarterly Accumulated Expenses of $87.7 million in Q1 2026, up 331.76% quarter-over-quarter from $20.3 million in Q4 2025, and up 1297.85% on a YoY basis from $6.3 million in Q1 2025.
Liquidia (LQDA) Accumulated Expenses (2019 - 2026) Analysis & Trends
Liquidia's Accumulated Expenses history runs 8 years deep, the most recent figure standing at $87.7 million for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 1297.85% year-over-year to $87.7 million; the TTM figure through Mar 2026 stood at $87.7 million (up 1297.85% YoY), while the FY2025 annual figure was $20.3 million, up 8.9% from the prior year.
- Accumulated Expenses was $87.7 million for Q1 2026 at Liquidia, up from $20.3 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $87.7 million in Q1 2026 to a low of $749000.0 in Q1 2023.
- Historically, Accumulated Expenses has averaged $13.7 million across 5 years, with a median of $6.3 million in 2025.
- Biggest YoY gain for Accumulated Expenses was 1778.24% in 2024; the steepest drop was 89.26% in 2024.
- A 5-year view of Accumulated Expenses shows it stood at $2.9 million in 2022, then soared by 198.53% to $8.5 million in 2023, then jumped by 118.39% to $18.7 million in 2024, then advanced by 8.9% to $20.3 million in 2025, then soared by 331.76% to $87.7 million in 2026.
- The last three Accumulated Expenses figures came in at $87.7 million (Q1 2026), $20.3 million (Q4 2025), and $40.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.73 Mn |
| Dec 31, 2025 | 20.32 Mn |
| Sep 30, 2025 | 40.44 Mn |
| Jun 30, 2025 | 853,000.00 |
| Mar 31, 2025 | 6.28 Mn |
| Dec 31, 2024 | 18.66 Mn |
| Sep 30, 2024 | 8.49 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 14.07 Mn |
| Dec 31, 2023 | 8.54 Mn |
| Sep 30, 2023 | 3.01 Mn |
| Jun 30, 2023 | 14.77 Mn |
| Mar 31, 2023 | 749,000.00 |
| Dec 31, 2022 | 2.86 Mn |
| Sep 30, 2022 | 2.20 Mn |
| Jun 30, 2022 | 1.92 Mn |
| Mar 31, 2022 | 845,000.00 |
| Dec 31, 2021 | 5.17 Mn |
| Sep 30, 2021 | 2.06 Mn |
| Jun 30, 2021 | 1.62 Mn |